Volume 34, Issue 6 e3008
REVIEW ARTICLE

Socio-economic status and HbA1c in type 2 diabetes: A systematic review and meta-analysis

Anne Bijlsma-Rutte

Corresponding Author

Anne Bijlsma-Rutte

Department of General Practice and Elderly Care Medicine, Amsterdam Public Health Research Institute, VU University Medical Center, Amsterdam, Netherlands

Correspondence

Anne Bijlsma-Rutte, Department of General Practice and Elderly Care Medicine, VU University Medical Centre, Van der Boechorststraat 7, BT Amsterdam 1081, the Netherlands.

Email: [email protected]

Search for more papers by this author
Femke Rutters

Femke Rutters

Department of Epidemiology and Biostatistics, Amsterdam Public Health Research Institute, VU University Medical Center, Amsterdam, Netherlands

Search for more papers by this author
Petra J.M. Elders

Petra J.M. Elders

Department of General Practice and Elderly Care Medicine, Amsterdam Public Health Research Institute, VU University Medical Center, Amsterdam, Netherlands

Search for more papers by this author
Sandra D.M. Bot

Sandra D.M. Bot

Department of General Practice and Elderly Care Medicine, Amsterdam Public Health Research Institute, VU University Medical Center, Amsterdam, Netherlands

Search for more papers by this author
Giel Nijpels

Giel Nijpels

Department of General Practice and Elderly Care Medicine, Amsterdam Public Health Research Institute, VU University Medical Center, Amsterdam, Netherlands

Search for more papers by this author
First published: 06 April 2018
Citations: 57

Summary

Up until now, differences in HbA1c levels by socio-economic status (SES) have been identified, but not yet quantified in people with type 2 diabetes. The aim of this study was therefore to assess the difference in HbA1c levels between people with type 2 diabetes of different SES in a systematic review and meta-analysis. A systematic literature search was conducted in MEDLINE, Embase, Ebsco, and the Cochrane Library until January 14, 2018. Included studies described adults with type 2 diabetes in whom the association between SES and HbA1c levels was studied. Studies were rated for methodological quality and data were synthesized quantitatively (meta-analysis) and qualitatively (levels of evidence), stratified for type of SES variable, i.e., education, income, deprivation, and employment. Fifty-one studies were included: 15 high, 27 moderate, and 9 of low methodological quality. Strong evidence was provided that people of low SES have higher HbA1c levels than people of high SES, for deprivation, education, and employment status. The pooled mean difference in HbA1c levels between people of low and high SES was 0.26% (95% CI, 0.09-0.43) or 3.12 mmol/mol (95% CI, 1.21-5.04) for education and 0.20% (95% CI, −0.05 to 0.46) or 2.36 mmol/mol (95%CI, −0.61 to 5.33) for income. In conclusion, our systematic review and meta-analysis showed that there was an inverse association between SES and HbA1c levels in people with type 2 diabetes. Future research should focus on finding SES-sensitive strategies to reduce HbA1c levels in people with type 2 diabetes.

CONFLICTS OF INTERESTS

The authors declare that they have no competing interests.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.